UnknownPhase 4NCT02715336

Efficacy and Safety of Medication Used to Stimulate Ovulation

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Create Fertility Center
Principal Investigator: Clifford Librach, MD
University of Toronto
Intervention: Ovulation induction with hCG and Lupron (GnRH agonist)(drug)
Enrollment: 666 target
Eligibility: 18-45 years · FEMALE
Timeline: 2015 – 2021

Study locations (1)

Create Fertility Centre, Toronto, Ontario, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02715336 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials